CAPR
NASDAQ · Biotechnology
Capricor Therapeutics Inc
$29.10
-2.07 (-6.64%)
Open$31.22
Previous Close$31.17
Day High$32.45
Day Low$29.09
52W High$40.37
52W Low$4.30
Volume—
Avg Volume1.99M
Market Cap1.72B
P/E Ratio—
EPS$-2.26
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
+114.6% upside
Current
$29.10
$29.10
Target
$62.44
$62.44
$34.96
$62.44 avg
$82.04
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 30.52M | 187.20M | 168.99M |
| Net Income | -55,455,340 | 36.18M | 32.84M |
| Profit Margin | -181.7% | 19.3% | 19.4% |
| EBITDA | -56,521,974 | 59.64M | 51.36M |
| Free Cash Flow | — | 19.67M | 27.43M |
| Rev Growth | +352.7% | +21.4% | +1.7% |
| Debt/Equity | 0.02 | 1.29 | 1.37 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |